In Brief: FDLI device meetings
This article was originally published in The Gray Sheet
Executive SummaryFDLI device meetings: Food and Drug Law Institute will hold a seminar Sept. 7 in Washington, D.C. on marketing and advertising of drugs, medical devices and biologics. The seminar "will provide an update on policy and enforcement issues involving the FDA, the FTC, State Attorneys General Offices and the Inspector General's Office," FDLI says. On Sept. 20, FDLI and FDA will present a live satellite video conference on FDA compliance issues. For more information call 202/371-1420..
You may also be interested in...
Executives On The Move: Comings And Goings At Atara Biothera And Pfizer, Along With A Promotion At Domainex
T-cell immunotherapy firm Atara Biotherapeutics decides on a chief commercial officer and Pfizer oncology R&D head leaves for CSO spot at Vividion Therapeutics. Also, COO of UK drug discovery CRO Domainex is set to climb to CEO position.
The World Trade Organization is not the place to discuss pharmaceutical pricing, and strong intellectual property rights do not threaten access to medicines, according to EU and US delegations to the WTO.
How do the EU’s new MDR cybersecurity guidelines expand on the MDR and fit into the myriad other software-related guidance documents the medtech industry has to consider?